OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 5.81
+0.10 (1.75%)
Apr 24, 2026, 4:49 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 81.62 million as of April 24, 2026. Its market cap has increased by 30.00% in one year.
Market Cap
81.62M
Enterprise Value
85.41M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.81
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 89.02M to 81.62M, a decrease of -8.31%. That is a compound annual growth rate of -1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 80.21M | -6.18% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IRLAB Therapeutics AB | 125.88M |
| Simris Group AB (PUBL) | 120.67M |
| Annexin Pharmaceuticals AB | 106.59M |
| Scandinavian ChemoTech AB | 104.62M |
| Biovica International AB | 95.16M |
| Magle Chemoswed Holding AB | 94.99M |
| Alzinova AB | 89.41M |
| Spago Nanomedical AB | 79.06M |